Table: begin end state 1 15 cytoplasmic 16 37 transmembrane 38 42 non-cytoplasmic 43 62 transmembrane 63 87 cytoplasmic 88 118 transmembrane 119 123 non-cytoplasmic 124 142 transmembrane 143 153 cytoplasmic 154 176 transmembrane 177 198 non-cytoplasmic 199 223 transmembrane 224 242 cytoplasmic 243 263 transmembrane 264 274 non-cytoplasmic 275 301 transmembrane 302 331 cytoplasmic 332 353 transmembrane 354 358 non-cytoplasmic 359 381 transmembrane 382 401 cytoplasmic 402 423 transmembrane 424 428 non-cytoplasmic 429 448 transmembrane 449 467 cytoplasmic
Input: >PP_5031 MQQAQGLKRGLSARHIRFMALGSAIGTGLFYGSASAIQMAGPAVLLAYLIGGAAVFMVMR ALGEMAVHNPVAGSFGHYATTYLGPMAGFILGWTYAFEMVIVAIADVTAFGIYMGFWFPE VARWIWVLGIVFLIGGLNLCNVKVFGEMEFWLSLLKVGAIVAMILAGLGIMAFGFSQVGT GHAVGMSNLFDHGGFMPNGVGGLIASFAVVMFAFGGIEIIGVTAGEAKDPQRVIPKAINA VPLRILLFYVLTLFVLMCLYPWPQIGSQGSPFVQIFSNLGIGSAAAVLNVVVISAAISAI NSDIFGAGRMMYGLAQQGHAPRGFSKLSKHGVPWMTVVVMGAALLIGVLLNYLIPENVFL LIASIATFATVWVWLMILLTQVAMRRSMSREQVAQLKFPVPFWPYGPAMAIAFMVFIFGV LGYFPDTQAALIVGVIWVVFLVASYLLWCKPRAGQGQPVAEPAELHR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server